The market for neurodegenerative diseases was estimated to be worth USD 39,125 million in 2020, and it is anticipated to grow to USD 78,295 million by 2035, showing a CAGR of 6.2% during the projected period (2020–2035).
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by